TrialHaematologica2012

Randomized phase II study of two schedules of flavopiridol given as timed sequential therapy with cytosine arabinoside and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia.

Judith E Karp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.